Healthcare >> CEO Interviews >> October 26, 2004
V. BRYAN LAWLIS JR. is President and Chief Executive Officer of Aradigm
Corporation. Prior to his promotion in June 2004, he held the position
of President and Chief Operating Officer and upon joining Aradigm in
2001 was the company's Chief Operating Officer. Previously, Dr. Lawlis
was a founder of Covance Biotechnology Services, a contract
biopharmaceutical manufacturing operation, and served as its President
and Chief Executive Officer from 1996 to 1999, and as Chairman from 1999
to 2001 when it was sold to Diosynth RTP, Inc., a division of Akzo
Nobel. From 1981 to 1996, Dr. Lawlis was employed at Genencor, Inc., and
Genentech, Inc., where his last position was Vice President of Process
Sciences. Dr. Lawlis hold a BA in Microbiology from the University of
Texas at Austin, and a PhD in Biochemistry from Washington State
University. Profile
technologies.
Dr. Lawlis: Aradigm was founded in 1994 and went public in 1996. We are
a drug delivery company with two
